Package 68071-3932-3

Brand: bupropion hydrochloride xl

Generic: bupropion hydrochloride
NDC Package

Package Facts

Identity

Package NDC 68071-3932-3
Digits Only 6807139323
Product NDC 68071-3932
Product ID 68071-3932_458c849e-ef08-54ae-e063-6294a90acd8b
Description

30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68071-3932-3)

Marketing

Marketing Status
Marketed Since 2025-12-09
Brand bupropion hydrochloride xl
Generic bupropion hydrochloride
Sample Package No

Linked Drug Pages (1)

Bupropion Hydrochloride XL ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "458c849e-ef08-54ae-e063-6294a90acd8b", "openfda": {"upc": ["0368071393231"], "unii": ["ZG7E5POY8O"], "rxcui": ["993541"], "spl_set_id": ["458c8a67-4995-c772-e063-6394a90a1f8d"], "manufacturer_name": ["NuCare Pharmaceuticals, Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68071-3932-3)", "package_ndc": "68071-3932-3", "marketing_start_date": "20251209"}], "brand_name": "Bupropion Hydrochloride XL", "product_id": "68071-3932_458c849e-ef08-54ae-e063-6294a90acd8b", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "68071-3932", "generic_name": "Bupropion Hydrochloride", "labeler_name": "NuCare Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bupropion Hydrochloride", "brand_name_suffix": "XL", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "150 mg/1"}], "application_number": "ANDA090693", "marketing_category": "ANDA", "marketing_start_date": "20170614", "listing_expiration_date": "20261231"}